This inventor holds 5 USPTO granted patents. Top assignees: Almirall Prodesfarma S.a., Fordonal, S.a., Laboratorios Almirall, S.a.. Active years: 1989-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 10 
1 out of 6 
1 out of 21 
Years Active: 1989-2009
Title: The Innovative Contributions of José Manuel Prieto Soto in Pharmaceutical Chemistry
Introduction: José Manuel Prieto Soto is a prominent inventor based in Barcelona, Spain, known for his significant contributions to pharmaceutical chemistry. With a total of three patents to his name, his work focuses on developing new therapeutic compounds that hold promise for medical applications. His innovative spirit and dedication to research continue to make a substantial impact in the field.
Latest Patents: Among his latest inventions are the pyrrolotriazolopyrimidinone derivatives. This patent details the creation of new and therapeutically useful compounds including 8-(disubstituted)phenyl-6,9-dihydro-5H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-c]pyrimidine-5-one and 8-phenyl-6,9-dihydro-5H-pyrrolo[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine-5-one derivatives. These compounds are designed for their potential use as potent and selective inhibitors of phosphodiesterase 5 (PDE 5), highlighting their relevance in treating various medical conditions. Another notable patent includes the development of 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives. This invention also focuses on compounds that serve as PDE 5 inhibitors, emphasizing their pharmaceutical significance.
Career Highlights: José Manuel Prieto Soto currently works at Almirall Prodesfarma S.A., a leading pharmaceutical company known for its research and development of innovative treatments. His role involves exploring new medicinal chemistry avenues and contributing to the advancement of drug formulations aimed at improving patient outcomes.
Collaborations: Throughout his career, José has collaborated with notable colleagues in the industry, including Bernat Vidal Juan and Jordi Gracia Ferrer. These partnerships have fostered a rich environment for creativity and innovation, paving the way for impactful advancements in pharmaceutical research.
Conclusion: José Manuel Prieto Soto exemplifies the spirit of innovation within the pharmaceutical sector. His contributions through multiple patents reflect a commitment to developing effective therapeutic solutions. As he continues his work at Almirall Prodesfarma S.A., the potential for future breakthroughs remains promising, positioning him as a key figure in the field of pharmaceutical chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile